FDA Works To Stay Focused As Heads Spin; Deputy Commissioners In Spotlight
Executive Summary
A key challenge for FDA following the resignation of Commissioner Lester Crawford will be overcoming the impression that being without a permanent leader yet again will result in a period of stasis at the agency
You may also be interested in...
FDA Gets Permanent Drug Safety Director In Advance Of Drug Center Overhaul
FDA's Office of Drug Safety will take on a higher profile position under a proposed reorganization of the Center for Drug Evaluation & Research
FDA Gets Permanent Drug Safety Director In Advance Of Drug Center Overhaul
FDA's Office of Drug Safety will take on a higher profile position under a proposed reorganization of the Center for Drug Evaluation & Research
Plan B Delay Draws Criticism From Congress, Academia, FDA Official
FDA's handling of Barr's application to switch Plan B over the counter could elicit heightened external scrutiny of the agency's ability to make drug approval decisions based solely on science and public health